Morpholino

MO1-cacnb2a

ID
ZDB-MRPHLNO-120511-10
Name
MO1-cacnb2a
Previous Names
None
Target
Sequence
5' - ATGCAACAGACACCTTGAGTAAAAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO. The author was contacted and provided the correct sequence.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-cacnb2a
Phenotype
Phenotype resulting from MO1-cacnb2a
Phenotype Fish Figures
blood circulation decreased process quality, abnormal WT + MO1-cacnb2a Fig. 5 with image from Chernyavskaya et al., 2012
cardiac ventricle decreased volume, abnormal WT + MO1-cacnb2a Fig. 5 with image from Chernyavskaya et al., 2012
cardiac ventricle has fewer parts of type cardiac muscle cell, abnormal WT + MO1-cacnb2a Fig. 7 from Chernyavskaya et al., 2012
cardiac ventricle cardiac muscle cell circular, abnormal s883Tg + MO1-cacnb2a Fig. 4 with image from Chernyavskaya et al., 2012
cardiac ventricle cardiac muscle cell decreased area, abnormal s883Tg + MO1-cacnb2a Fig. 4 with image from Chernyavskaya et al., 2012
cardiac ventricle sarcomere organization decreased process quality, abnormal s883Tg + MO1-cacnb2a Fig. 10 with image from Chernyavskaya et al., 2012
cell adhesion involved in heart morphogenesis decreased process quality, abnormal f2Tg + MO1-cacnb2a Fig. 9 with image from Chernyavskaya et al., 2012
cell proliferation involved in heart morphogenesis decreased occurrence, abnormal WT + MO1-cacnb2a Fig. 8 with image from Chernyavskaya et al., 2012
cell-cell adhesion mediated by cadherin decreased process quality, abnormal s883Tg + MO1-cacnb2a Fig. 10 with image from Chernyavskaya et al., 2012
heart decreased contractility, abnormal WT + MO1-cacnb2a Fig. 2 with image from Chernyavskaya et al., 2012
heart edematous, abnormal WT + MO1-cacnb2a Fig. 2 with image from Chernyavskaya et al., 2012
heart malformed, abnormal WT + MO1-cacnb2a Fig. 2 with imageFig. 3 with image from Chernyavskaya et al., 2012
heart contraction decreased process quality, abnormal WT + MO1-cacnb2a Fig. 2 with image from Chernyavskaya et al., 2012
heart contraction decreased rate, abnormal WT + MO1-cacnb2a Fig. 5 with image from Chernyavskaya et al., 2012
heart looping decreased process quality, abnormal WT + MO1-cacnb2a Fig. 2 with imageFig. 3 with image from Chernyavskaya et al., 2012
heart tube increased fragility, abnormal f2Tg + MO1-cacnb2a Fig. 9 with image from Chernyavskaya et al., 2012
Phenotype of all Fish created by or utilizing MO1-cacnb2a
Phenotype Fish Conditions Figures
heart malformed, abnormal WT + MO1-cacnb2a standard conditions Fig. 2 with image from Chernyavskaya et al., 2012
heart contraction decreased process quality, abnormal WT + MO1-cacnb2a standard conditions Fig. 2 with image from Chernyavskaya et al., 2012
cell proliferation involved in heart morphogenesis decreased occurrence, abnormal WT + MO1-cacnb2a standard conditions Fig. 8 with image from Chernyavskaya et al., 2012
heart edematous, abnormal WT + MO1-cacnb2a standard conditions Fig. 2 with image from Chernyavskaya et al., 2012
heart looping decreased process quality, abnormal WT + MO1-cacnb2a standard conditions Fig. 2 with image from Chernyavskaya et al., 2012
cardiac ventricle decreased volume, abnormal WT + MO1-cacnb2a standard conditions Fig. 5 with image from Chernyavskaya et al., 2012
heart decreased contractility, abnormal WT + MO1-cacnb2a standard conditions Fig. 2 with image from Chernyavskaya et al., 2012
blood circulation decreased process quality, abnormal WT + MO1-cacnb2a standard conditions Fig. 5 with image from Chernyavskaya et al., 2012
heart contraction decreased rate, abnormal WT + MO1-cacnb2a standard conditions Fig. 5 with image from Chernyavskaya et al., 2012
cardiac ventricle has fewer parts of type cardiac muscle cell, abnormal WT + MO1-cacnb2a standard conditions Fig. 7 from Chernyavskaya et al., 2012
cell adhesion involved in heart morphogenesis decreased process quality, abnormal f2Tg + MO1-cacnb2a standard conditions Fig. 9 with image from Chernyavskaya et al., 2012
heart tube increased fragility, abnormal f2Tg + MO1-cacnb2a standard conditions Fig. 9 with image from Chernyavskaya et al., 2012
cardiac ventricle cardiac muscle cell decreased area, abnormal s883Tg + MO1-cacnb2a standard conditions Fig. 4 with image from Chernyavskaya et al., 2012
cardiac ventricle sarcomere organization decreased process quality, abnormal s883Tg + MO1-cacnb2a standard conditions Fig. 10 with image from Chernyavskaya et al., 2012
heart malformed, abnormal s883Tg + MO1-cacnb2a standard conditions Fig. 3 with image from Chernyavskaya et al., 2012
heart looping decreased process quality, abnormal s883Tg + MO1-cacnb2a standard conditions Fig. 3 with image from Chernyavskaya et al., 2012
cardiac ventricle cardiac muscle cell circular, abnormal s883Tg + MO1-cacnb2a standard conditions Fig. 4 with image from Chernyavskaya et al., 2012
cell-cell adhesion mediated by cadherin decreased process quality, abnormal s883Tg + MO1-cacnb2a standard conditions Fig. 10 with image from Chernyavskaya et al., 2012
Citations